Alex Lobo
Stern Investor Relations
Replay available
Inhibikase Therapeutics, Inc. (IKT) Q4 2023 Earnings Call
Inhibikase Therapeutics, Inc. (NASDAQ: IKT) Q4 2023 earnings conference call, held 2024-03-28. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Milton Werner
Chief Executive Officer
Garth Lees-Ross
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Inhibikase Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:01.790 Ladies and gentlemen, thank you for standing by. 00:00:01.790 -- 00:00:06.491 Greetings and welcome to Inhibit Case Therapeutics' fourth quarter and full year 2023 00:00:06.491 -- 00:00:10.673 financial results. At this time, all participants will be in listen-only mode. 00:00:10.673 -- 00:00:14.774 The question and answer session will follow the formal presentation. 00:00:14.855 -- 00:00:18.276 Please note that today's conference is being recorded, and if you should require operator 00:00:18.276 -- 00:00:21.797 assistance, you may press star zero from your telephone keypad. 00:00:21.797 -- 00:00:25.739 I'll now turn the call over to Alex Lobo, Stern Investor Relations. 00:00:25.739 -- 00:00:26.679 Alex, you may now begin. 00:00:26.679 -- 00:00:28.679 Thank 00:00:28.920 -- 00:00:32.917 you, operator. Good morning and welcome to Inhibit Case Therapeutics' fourth quarter 00:00:32.917 -- 00:00:37.658 and full year 2023 financial results conference call and audio webcast. 00:00:37.658 -- 00:00:42.759 With me today is Dr. Milton Werner, Chief Executive Officer, and Garth Lees-Ross, 00:00:42.759 -- 00:00:44.800 Chief Financial Officer. 00:00:44.800 -- 00:00:49.281 On March 27th, Inhibit Case issued a press release announcing financial results for the 00:00:49.281 -- 00:00:52.142 fourth quarter and full year ended December 31st, 2023. 00:00:52.142 -- 00:00:54.402 We encourage 00:00:54.523 -- 00:00:58.964 everybody to read yesterday's press release as well as Inhibit Case's annual report on 00:00:58.964 -- 00:01:03.098 Form 10-K. which has been filed with the SEC. 00:01:03.098 -- 00:01:07.660 The company's press release and annual report are also available on Inhibicase's website 00:01:07.660 -- 00:01:09.820 at inhibicase.com. 00:01:10.541...